Real-time enrollment status for this acquired angioedema due to c1-inhibitor deficiency (aae-c1-inh) clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 12:49 AM UTC
| NCT Number | NCT07266805 |
| Recruiting Status | Recruiting |
| Condition | Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) |
| Phase | PHASE3 |
| Target Enrollment | 48 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Pharvaris Netherlands B.V. |
| Last Updated on CT.gov | September 21, 2026 (4 weeks ago) |
As of October 19, 2026: Clinical trial NCT07266805 is currently recruiting participants. This phase3 study for acquired angioedema due to c1-inhibitor deficiency (aae-c1-inh) is actively seeking new participants at 4 locations across the United States. The study is sponsored by Pharvaris Netherlands B.V.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07266805 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07266805 was last updated 4 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.